MEDIA RELEASE PR37014
Forecast Looks Good for India Pharma Shows
MAARSSEN, Nov. 10 /PRNewswire-AsiaNet/ --
Momentum is building for the early December staging in Mumbai of the
third CPhI India and second P-MEC India pharma ingredients, services and
technologies event. A combined total of over 600 exhibitors from over 80
countries are expected at the Bombay Exhibition Centre for the 2009 events,
being held on 1 - 3 December.
In addition to high quality exhibitors, the 2009 events include two new
launches. BioPh India will focus on the convergence of technologies and
business models in pharma and healthcare biotechnology - especially across
the common interest areas of innovation, product development, clinical
trials, manufacturing and supply logistics.
2009 also brings the debut of ICSE India, with emphasis on the very
fast-growing outsourcing and contract services sector. The co-located
additions of BioPh India and ICSE India to CPhI India and P-MEC India add
impressive further depth and networking value to the combined events. The
2009 events will also be complemented by two major conferences.
CPhI India became the fourth member of the brand's global event "family"
in 2006 and was joined by P-MEC India in 2007. The combined exhibitions are
the largest pharma services event in India and South Asia. Despite the recent
global slowdown, Indian pharma has maintained standout growth rates, with a
sector forecast to quadruple, from US $6.3bn. in 2005 to US $25bn. in 2015.
In their mid-2009 report, and underlining the important addition of ICSE
India - E&Y/OPPI (Ernst & Young/Organisation of Pharmaceutical Producers of
India - OPPI) noted that India's outsourcing sector is growing at 43%, with
drug discovery and development segment growing at 65% - well over three times
the global average. India is targeting to become one of the top five
innovator countries by 2020.
Growth will figure strongly in the major conferences complementing the
exhibitions. These begin with the Indian Pharma Summit on Monday 30 November,
focusing on: "The future of India Pharma - India Pharma Vision 2020"
addressing the issues, opportunities and challenges for India as an emerging
global pharma hub.
The event will be chaired by Ashok Kumar, Secty. Dept. of Pharmaceuticals
and co-chaired by Glenn Saldhana, Chairman, FICCI National Pharmaceuticals
Committee & MD and CEO, Glenmark Pharmaceuticals. Organisers are the
Government of India's new Department of Pharmaceuticals and UBM India Pvt.
Ltd. Venue is the Mumbai Grand Hyatt.
Staged alongside the first two days of CPhI India, in the BioPh pavilion
at the Bombay Exhibition Centre, Biosimilars India 2009 will cover a wide
range of topics in 17 sessions across three half-day modules.
"India is now moving towards centrestage in world pharma, with its
overall pharma market growing at better than 9% - and key segments much
faster. CPhI and the co-located events are the natural meeting point that
enables a high level of networking and business development across the
academic, development, R&D, services and manufacturing communities," said
CPhI India Event Director Annemieke Timmers.
"With the BioPh India and ICSE India launches and a strong conference
programme adding to a high level of pre-registrations, all our indications
are that this year in Mumbai will see our strongest Indian events so far,"
added ICSE, BioPh and P-MEC Event Director Haf Cennydd.
Key industry organisations supporting the exhibitions will include
Pharmexcil - the Government of India's pharmaceutical export promotion
council; the Indian Drug Manufacturers Association (IDMA); the Organisation
of Pharmaceutical Producers of India (OPPI) and the Bulk Drug Manufacturers
Association (India) (BDMA).
The events are jointly organised by UBM International Media and sister
company UBM India Pvt. Ltd.
UBM International Media's annual sister events for the pharma ingredients
and services sector include Worldwide (Europe - October); Japan (April);
China (June); and South America (August). For websites, see:
Notes for Editors:
-- UBM International Media operates market-leading global exhibition
brands and their complementary media products.
-- The CPhI pharmaceutical ingredients and related sector exhibitions
currently number over 12 highly-regarded annual events. The portfolio
also includes Informex (speciality chemicals), Food Ingredients, HBA
(health & beauty industry) and Sea Trade (cruise industry).
-- Worldwide locations for its events include China, India, Japan, North
America, Brazil, Africa and Europe. More than 330,000 business
professionals and marketers visit UBM exhibitions each year. The
exhibitions portfolio is managed from Holland. UBM International Media
has approximately 1,200 employees in the UK, US, Asia and Europe. See
SOURCE: CPhI India
CONTACT: Rob Sahi (CPhI),
+ 31(0)346-559-461,
or Ian O'Malley (ICSE, P-MEC, BioPh),
+ 31(0)346-559-426,
both of UBM International Media;
or Roger Johnstone of GyroHSR Public Relations,
+44(0)161-614-1450
NEWS 
